Trials / Completed
CompletedNCT03864510
NAFLD in Diabetes Type 2 in Primary Care
Evaluating Prevalence and Severity of NAFLD In Primary Care
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 317 (actual)
- Sponsor
- Linkoeping University · Other Government
- Sex
- All
- Age
- 35 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The EPSONIP (Evaluating Prevalence and Severity Of NAFLD In Primary care) trial is a longitudinal cohort study of patients with T2DM recruited from primary health care centers in Östergötland, Sweden. The latest MRI techniques will be used to quantify the amount of hepatic fat, inflammation, liver fibrosis and body composition. Each patient will be investigated twice with three years apart to determine patients with progressive disease.
Conditions
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
- First posted
- 2019-03-06
- Last updated
- 2025-12-12
Locations
2 sites across 1 country: Sweden
Source: ClinicalTrials.gov record NCT03864510. Inclusion in this directory is not an endorsement.